Clinical Roundup Loxo Oncology announces larotrectinib clinical update in patients with TRK Fusion cancers October 26, 2018Vol.44 No.40
Clinical Roundup Pfizer provides update on PALOMA-3 trial of IBRANCE in HR+, HER2- metastatic breast cancer October 26, 2018Vol.44 No.40
Clinical Roundup Data monitoring committee recommends continuation of SGX301 trial in cutaneous T-cell lymphoma October 26, 2018Vol.44 No.40
Clinical Roundup Data on Merck’s investigational STING agonist presented at ESMO 2018 October 26, 2018Vol.44 No.40
Clinical Roundup Zoledronic acid improves DFS in premenopausal HR+ early breast cancer October 26, 2018Vol.44 No.40
Clinical Roundup SOLO-1 phase III trial demonstrates Lynparza maintenance therapy cut the risk of disease progression or death by 70% in advanced BRCA-mutated ovarian cancer October 26, 2018Vol.44 No.40
Clinical Roundup Study shows surgery, radiation extend survival of patients with limited metastatic lung cancer October 26, 2018Vol.44 No.40
Clinical Roundup AVEO Oncology, EUSA Pharma announce updated interim results from phase II portion of the TiNivo study in renal cell carcinoma October 26, 2018Vol.44 No.40
Clinical Roundup Celsion announces PFS data from GEN-1 phase I immuno-oncology study in stage III/IV ovarian cancer October 26, 2018Vol.44 No.40
